Prime Medicine, Inc. CAMBRIDGE, Mass. , Feb. 24, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one ...
In NHL.com’s Q&A feature called “Sitting Down with …” we talk to key figures in the game, gaining insight into their lives on ...
Undoubtedly 7-11 is a household name in Thailand, but did you know they're also a quick and easy spot for readily available ...
CAMBRIDGE, Mass. , Feb. 24, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic ...
-- On track to report initial data from Phase 1/2 clinical trial of PM359 for p47 phox CGD in 2025 -- -- IND-enabling studies ongoing for PM577 for Wilson’s Disease; expect to file IND and/or ...
The trial, called Project Caelus, suggests life-saving medical supplies could soon be airborne, transforming health care across Scotland — especially in rural communities.
This ultra-thin voice recorder uses AI to record, transcribe, format, and organise your conversations, giving you a summary ...
CAMBRIDGE, Mass. , Feb. 24, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic ...
(MENAFN- GlobeNewsWire - Nasdaq) -- On track to report initial data from Phase 1/2 clinical trial of PM359 for p47 phox CGD in 2025 -- -- IND-enabling studies ongoing for PM577 for Wilson's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback